CARES Act, considerations for private equity funds with corporate portfolio companies (COVID-19)
CARES Act, considerations for private equity funds
Private equity funds and their corporate portfolio companies may benefit significantly from the net operating loss (NOL) and other tax provisions included in the “Coronavirus Aid, Relief, and Economic Security Act” (CARES Act).
A report prepared by KPMG LLP highlights certain income tax provisions, and resulting opportunities, relevant to the operation and the acquisition/disposition of private equity portfolio companies that are classified as corporations for U.S. federal tax purposes.
Read the April 2020 report [PDF 121 KB] prepared by KPMG LLP: What’s News in Tax: The CARES Act: Considerations for Private Equity Funds with Corporate Portfolio Companies
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.